Binocular visual function after staged implantation of extended-depth-of-focus intraocular lens targeting emmetropia and -0.5 diopter: A prospective comparison.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 15 06 2020
accepted: 09 08 2020
entrez: 26 8 2020
pubmed: 26 8 2020
medline: 21 10 2020
Statut: epublish

Résumé

The prospective comparative case series aimed to evaluate the binocular uncorrected visual acuities (BUCVAs) after staged implantations of extended-depth-of-focus intraocular lenses (EDOF IOLs) targeting emmetropia and -0.5 diopter (D). Diffractive EDOF IOLs with an add power of +1.75 D were implanted in the first eyes targeting emmetropia or -0.5 D according to the patients' preferences, then the targets for the second eyes were determined 1 week or longer after the implantation. IOL powers were determined with the SRK/T formula. Consequently, the subjects were divided into 3 groups: those with emmetropia targeted bilaterally (group EE, 22 patients), those with -0.5 D targeted bilaterally (group MM, 21 patients), and those with monovision of emmetropia and -0.5 D (group EM, 21 patients). Manifest refraction spherical equivalent (MRSE), BUCVA from 0.3 to 5 meters, spectacle use, and questionnaire regarding photic symptoms and patient satisfaction were assessed 3 months postoperatively. No significant differences were seen in the mean BUCVAs at any distance (P > 0.23), spectacle use (P = 0.13), or photic symptoms and patient satisfaction (P>0.65). When the EE and MM groups were assigned based on the MRSE, the EE group was better at 5 m (P = 0.005) while the MM group at 0.5 m (P = 0.031). The effect of different targeted refractions was not identified due to insufficient accuracy in the use of the SRK/T power calculation.

Identifiants

pubmed: 32841287
doi: 10.1371/journal.pone.0238135
pii: PONE-D-20-18251
pmc: PMC7447018
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0238135

Déclaration de conflit d'intérêts

The authors have read the journal policies and the authors have the following competing interests to declare: The study was supported by Johnson & Johnson Surgical Vision. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Nippon Ganka Gakkai Zasshi. 1980 Oct 10;84(10):1619-28
pubmed: 7257979
Biomed Opt Express. 2017 Aug 31;8(9):4294-4309
pubmed: 28966865
J Cataract Refract Surg. 2012 Jul;38(7):1181-6
pubmed: 22727287
Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):863-875
pubmed: 30627791
Clin Ophthalmol. 2018 Nov 12;12:2305-2312
pubmed: 30518994
Jpn J Ophthalmol. 2018 Mar;62(2):226-230
pubmed: 29264862
J Cataract Refract Surg. 2016 Oct;42(10):1490-1500
pubmed: 27839605
Asia Pac J Ophthalmol (Phila). 2017 Jul-Aug;6(4):339-349
pubmed: 28780781
Cochrane Database Syst Rev. 2016 Dec 12;12:CD003169
pubmed: 27943250
J Cataract Refract Surg. 2016 Sep;42(9):1268-1275
pubmed: 27697244
Am J Ophthalmol. 2019 Mar;199:223-229
pubmed: 30552894
J Refract Surg. 2016 Jul 1;32(7):436-42
pubmed: 27400074
Ophthalmology. 2018 Feb;125(2):169-178
pubmed: 28951074
J Cataract Refract Surg. 2019 Oct;45(10):1398-1403
pubmed: 31444080
Surv Ophthalmol. 2017 Sep - Oct;62(5):611-634
pubmed: 28366683
J Refract Surg. 2017 Apr 1;33(4):218-222
pubmed: 28407160

Auteurs

Yuka Ota (Y)

Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, Tokyo, Japan.

Hiroko Bissen-Miyajima (H)

Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, Tokyo, Japan.

Kunihiko Nakamura (K)

Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, Tokyo, Japan.

Manabu Hirasawa (M)

Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, Tokyo, Japan.

Keiichiro Minami (K)

Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH